Bionomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 112.3%.

Top 22 shareholders own 28.84% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.08%	Armistice Capital LLC	1,226,759	€310.7k	0%	0.01%
5.65%	Apeiron Investment Group	978,831	€247.9k	-4.44%	0.54%
5.5%	BVF Partners L.P.	952,503	€241.3k	0%	0.01%
4.57%	Presight Capital	790,787	€200.3k	0%	1.43%
3.46%	Lynx1 Capital Management LP	599,673	€151.9k	-26.4%	0.1%
1.82%	Point72 Asset Management, L.P.	316,000	€80.0k	0%	no data
0.2%	UBS Asset Management AG	34,897	€8.8k	251%	no data
0.15%	Two Sigma Securities, LLC, Asset Management Arm	26,038	€6.6k	0%	no data
0.13%	Lewis Asset Management, LLC	23,000	€5.8k	53.3%	0.01%
0.095%	Two Sigma Investments, LP	16,370	€4.1k	-4.1%	no data
0.063%	XTX Holdings Limited, Asset Management Arm	10,940	€2.8k	0%	no data
0.058%	Beacon Pointe Advisors, LLC	10,000	€2.5k	0%	no data
0.013%	Rhumbline Advisers Ltd Partnership	2,195	€555.8	68.2%	no data
0.012%	Errol De Souza	2,053	€519.9	0%	no data
0.0087%	Peter Miles Davies	1,511	€382.5	0%	no data
0.0081%	David Wilson	1,410	€357.1	0%	no data
0.0046%	Morgan Stanley, Investment Banking and Brokerage Investments	794	€200.9	745%	no data
0.0041%	Elizabeth Doolin	714	€180.7	0%	no data
0.0032%	Alan Fisher	560	€141.7	0%	no data
0.0023%	Adrian Hinton	392	€99.1	0%	no data
0.0011%	Aspire Private Capital, LLC	200	€50.5	0%	no data
0.00001%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€0.4	0%	no data